A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

August 30, 2021

Study Completion Date

August 30, 2021

Conditions

Alzheimer Dementia

Interventions

DRUG

Methylphenidate Extended Release Oral Capsule

"Stimulant It can treat ADHD and narcolepsy.~1 capsule 18mg"

OTHER

Placebo

Placebo comparator MPH Matched Placebo Tablet

Trial Locations (1)

Massachusetts General Hospital, Clinical Translational Research Unit, Charlestown

All Listed Sponsors

lead

Massachusetts General Hospital

OTHER

NCT03811847 - A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants. | Biotech Hunter | Biotech Hunter